Michael Thomas Schweizer
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
Papers in
-
- Prostate Cancer Treatment and Research 95
- Prostate Cancer Diagnosis and Treatment 6
- Oncology 24
- Cancer Immunotherapy and Biomarkers 10
- COVID-19 and healthcare impacts 6
- PARP inhibition in cancer therapy 6
- Co-authors
- Emmanuel S. Antonarakis (23 shared papers)Mario A. Eisenberger (11 shared papers)Evan Y. Yu (35 shared papers)Peter Nelson (34 shared papers)Robert Bruce Montgomery (33 shared papers)Colin C. Pritchard (17 shared papers)Heather H. Cheng (26 shared papers)Rosa Nadal (5 shared papers)
- Journals
- The Prostate (12 papers)JCO Precision Oncology (9 papers)Clinical Cancer Research (8 papers)European Urology (7 papers)Clinical Genitourinary Cancer (7 papers)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Michael Thomas Schweizer
137 papers receiving 5.4k citations
Michael Thomas Schweizer's Hit Papers
Peers
Comparison fields: 5 of 89
- Pulmonary and Respiratory Medicine 3.5k
- Oncology 865
- Cancer Research 362
- Infectious Diseases 204
- Radiology, Nuclear Medicine and Imaging 170
Countries citing papers authored by Michael Thomas Schweizer
This map shows the geographic impact of Michael Thomas Schweizer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Thomas Schweizer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Thomas Schweizer more than expected).
Fields of papers citing papers by Michael Thomas Schweizer
This network shows the impact of papers produced by Michael Thomas Schweizer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Thomas Schweizer. The network helps show where Michael Thomas Schweizer may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Thomas Schweizer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling Hit paper breakdown → | 2017 | 574 |
| 2 | Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer Hit paper breakdown → | 2019 | 326 |
| 3 | 2015 | 214 | |
| 4 | 2014 | 204 | |
| 5 | 2018 | 182 | |
| 6 | 2017 | 157 | |
| 7 | 2021 | 156 | |
| 8 | 2020 | 135 | |
| 9 | 2019 | 133 | |
| 10 | 2017 | 128 | |
| 11 | 2014 | 119 | |
| 12 | 2020 | 114 | |
| 13 | 2018 | 112 | |
| 14 | 2021 | 101 | |
| 15 | 2018 | 96 | |
| 16 | 2014 | 86 | |
| 17 | 2019 | 86 | |
| 18 | 2013 | 85 | |
| 19 | 2020 | 80 | |
| 20 | 2019 | 79 |
About Michael Thomas Schweizer
Michael Thomas Schweizer is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 149 papers that have together received 5.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (95 papers), Bladder and Urothelial Cancer Treatments (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Cancer Genomics and Diagnostics (9 papers), Radiopharmaceutical Chemistry and Applications (6 papers), COVID-19 and healthcare impacts (6 papers), PARP inhibition in cancer therapy (6 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.5k citations), Oncology (865 citations), Cancer Research (362 citations), Infectious Diseases (204 citations) and Radiology, Nuclear Medicine and Imaging (170 citations). Michael Thomas Schweizer has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Emmanuel S. Antonarakis, Mario A. Eisenberger, Evan Y. Yu, Peter Nelson, Robert Bruce Montgomery, Colin C. Pritchard, Heather H. Cheng, Rosa Nadal, Michael Anthony Carducci and Jonathan I. Epstein. Their work appears in journals such as The Prostate, JCO Precision Oncology, Clinical Cancer Research, European Urology and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.